Bo Guo

3.9k total citations · 1 hit paper
86 papers, 2.7k citations indexed

About

Bo Guo is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Bo Guo has authored 86 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 22 papers in Immunology and 22 papers in Cancer Research. Recurrent topics in Bo Guo's work include MicroRNA in disease regulation (18 papers), RNA modifications and cancer (13 papers) and Cancer-related molecular mechanisms research (13 papers). Bo Guo is often cited by papers focused on MicroRNA in disease regulation (18 papers), RNA modifications and cancer (13 papers) and Cancer-related molecular mechanisms research (13 papers). Bo Guo collaborates with scholars based in China, United States and Norway. Bo Guo's co-authors include Chen Huang, Huaixing Cang, Danyang Li, Jing Wang, Bo Zhu, Weidong Han, Yao Wang, Hui Fan, Haiyan Lv and Qingwang Han and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Bo Guo

78 papers receiving 2.7k citations

Hit Papers

Genetic association of lipids and lipid-lowering drug tar... 2023 2026 2024 2025 2023 20 40 60

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bo Guo China 31 1.4k 779 699 657 252 86 2.7k
Kishore K. Wary United States 31 2.8k 2.0× 842 1.1× 547 0.8× 718 1.1× 260 1.0× 66 4.9k
Joni D. Mott United States 18 1.3k 0.9× 818 1.1× 967 1.4× 302 0.5× 209 0.8× 25 2.7k
Justin P. Annes United States 19 1.6k 1.1× 530 0.7× 514 0.7× 816 1.2× 431 1.7× 46 3.4k
Maria Carla Bosco Italy 32 1.1k 0.8× 807 1.0× 770 1.1× 1.7k 2.5× 217 0.9× 81 3.3k
Fawzi Aoudjit Canada 28 1.2k 0.9× 567 0.7× 1.0k 1.4× 862 1.3× 94 0.4× 61 2.7k
Roland P. Piekorz Germany 33 1.6k 1.1× 396 0.5× 1.0k 1.5× 1.1k 1.6× 245 1.0× 75 3.4k
Bin Pan China 25 1.7k 1.2× 759 1.0× 539 0.8× 631 1.0× 139 0.6× 106 2.9k
Yueying Liu United States 28 1.3k 0.9× 642 0.8× 900 1.3× 322 0.5× 100 0.4× 94 3.0k
Bing Chen China 27 2.0k 1.4× 1.2k 1.6× 470 0.7× 375 0.6× 115 0.5× 151 3.1k

Countries citing papers authored by Bo Guo

Since Specialization
Citations

This map shows the geographic impact of Bo Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Guo more than expected).

Fields of papers citing papers by Bo Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Guo. The network helps show where Bo Guo may publish in the future.

Co-authorship network of co-authors of Bo Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Guo. A scholar is included among the top collaborators of Bo Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Guo. Bo Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
3.
Guo, Bo, Xinhao Zhao, Zheng Sun, et al.. (2024). Evaluation of benefits and risks of immunosuppressive drugs in biomaterial-based neural progenitor cell transplantation for spinal cord injury repair. Chemical Engineering Journal. 487. 150404–150404. 3 indexed citations
4.
Li, Ziang, Bin Zhang, Qing‐Rong Liu, et al.. (2023). Genetic association of lipids and lipid-lowering drug target genes with non-alcoholic fatty liver disease. EBioMedicine. 90. 104543–104543. 66 indexed citations breakdown →
5.
Qin, Yannan, Haiqing Zhang, Bo Guo, et al.. (2022). Whole-Transcriptome Analysis of Serum L1CAM-Captured Extracellular Vesicles Reveals Neural and Glycosylation Changes in Autism Spectrum Disorder. Journal of Molecular Neuroscience. 72(6). 1274–1292. 19 indexed citations
6.
Fu, Yong, Yan Ding, Qinghui Wang, et al.. (2020). Blood-stage malaria parasites manipulate host innate immune responses through the induction of sFGL2. Science Advances. 6(9). eaay9269–eaay9269. 20 indexed citations
7.
Wang, Jing, Danyang Li, Huaixing Cang, & Bo Guo. (2019). Crosstalk between cancer and immune cells: Role of tumor‐associated macrophages in the tumor microenvironment. Cancer Medicine. 8(10). 4709–4721. 253 indexed citations
8.
9.
Guo, Bo, Zhenghao Zhao, Qian Li, et al.. (2017). Rab14 Act as Oncogene and Induce Proliferation of Gastric Cancer Cells via AKT Signaling Pathway. PLoS ONE. 12(1). e0170620–e0170620. 39 indexed citations
10.
Han, Jia, Jie Li, Huahua Zhang, et al.. (2017). miR-338-3p confers 5-fluorouracil resistance in p53 mutant colon cancer cells by targeting the mammalian target of rapamycin. Experimental Cell Research. 360(2). 328–336. 49 indexed citations
11.
Gao, Jianbao, Lintao Zhao, Lina Liu, et al.. (2017). Disrupted fibroblastic reticular cells and interleukin-7 expression in tumor draining lymph nodes. Oncology Letters. 14(3). 2954–2960. 14 indexed citations
12.
Guo, Bo, et al.. (2016). Clinical presentation and treatment outcome of retinoblastoma in children of South Western China. Medicine. 95(42). e5204–e5204. 38 indexed citations
13.
He, Kang, Dongdong Tong, Si Zhang, et al.. (2015). miRNA-99b-3p functions as a potential tumor suppressor by targeting glycogen synthase kinase-3β in oral squamous cell carcinoma Tca-8113 cells. International Journal of Oncology. 47(4). 1528–1536. 30 indexed citations
14.
Wang, Wei, Ling Zhao, Bo Guo, et al.. (2014). Silencing of polo-like kinase 2 increases cell proliferation and decreases apoptosis in SGC-7901 gastric cancer cells. Molecular Medicine Reports. 11(4). 3033–3038. 8 indexed citations
15.
Wang, Quanshun, Yao Wang, Haiyan Lv, et al.. (2014). Treatment of CD33-directed Chimeric Antigen Receptor-modified T Cells in One Patient With Relapsed and Refractory Acute Myeloid Leukemia. Molecular Therapy. 23(1). 184–191. 330 indexed citations
16.
Guo, Bo, Liying Liu, Jiayi Yao, et al.. (2013). miR-338-3p Suppresses Gastric Cancer Progression through a PTEN-AKT Axis by Targeting P-REX2a. Molecular Cancer Research. 12(3). 313–321. 74 indexed citations
17.
Xu, Gui‐lian, Ke‐Qin Zhang, Bo Guo, et al.. (2010). Induction of protective and therapeutic antitumor immunity by a DNA vaccine with C3d as a molecular adjuvant. Vaccine. 28(44). 7221–7227. 9 indexed citations
18.
Gao, Yuzhen, Yan He, Jian Ding, et al.. (2009). An insertion/deletion polymorphism at miRNA-122-binding site in the interleukin-1  3' untranslated region confers risk for hepatocellular carcinoma. Carcinogenesis. 30(12). 2064–2069. 127 indexed citations
19.
Tang, Lei, Bo Guo, Amjad Javed, et al.. (1999). Crystal Structure of the Nuclear Matrix Targeting Signal of the Transcription Factor Acute Myelogenous Leukemia-1/Polyoma Enhancer-binding Protein 2αB/Core Binding Factor α2. Journal of Biological Chemistry. 274(47). 33580–33586. 68 indexed citations
20.
Guo, Bo, Haiyan Li, & Lingqi Zhang. (1998). Isolation of an fungus producting vinbrastine. Yunnan Daxue xuebao. Shehui kexue ban. 20(3). 214–215. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026